Collen D - Search Results

1

Thrombolysis with human extrinsic (tissue-type) plasminogen activator in dogs with femoral vein thrombosis.

Korninger C, Matsuo O, Suy R, Stassen JM, Collen D. Korninger C, et al. Among authors: collen d. J Clin Invest. 1982 Mar;69(3):573-80. doi: 10.1172/jci110483. J Clin Invest. 1982. PMID: 7199539 Free PMC article.

2

Influence of the fast-acting inhibitor of plasminogen activator on in vivo thrombolysis induced by tissue-type plasminogen activator in rabbits. Interference of tissue-derived components.

Colucci M, Paramo JA, Stassen JM, Collen D. Colucci M, et al. Among authors: collen d. J Clin Invest. 1986 Jul;78(1):138-44. doi: 10.1172/JCI112543. J Clin Invest. 1986. PMID: 3088040 Free PMC article.

3

Thrombolysis with human extrinsic (tissue-type) plasminogen activator in rabbits with experimental jugular vein thrombosis. Effect of molecular form and dose of activator, age of the thrombus, and route of administration.

Collen D, Stassen JM, Verstraete M. Collen D, et al. J Clin Invest. 1983 Feb;71(2):368-76. doi: 10.1172/jci110778. J Clin Invest. 1983. PMID: 6681615 Free PMC article.

4

Plasminogen activator inhibitor-1 gene-deficient mice. II. Effects on hemostasis, thrombosis, and thrombolysis.

Carmeliet P, Stassen JM, Schoonjans L, Ream B, van den Oord JJ, De Mol M, Mulligan RC, Collen D. Carmeliet P, et al. Among authors: collen d. J Clin Invest. 1993 Dec;92(6):2756-60. doi: 10.1172/JCI116893. J Clin Invest. 1993. PMID: 8254029 Free PMC article.

5

Enhancement of clot lysis in vitro and in vivo with a bispecific monoclonal antibody directed against human fibrin and against urokinase-type plasminogen activator.

Kurokawa T, Iwasa S, Kakinuma A, Stassen JM, Lijnen HR, Collen D. Kurokawa T, et al. Among authors: collen d. Thromb Haemost. 1991 Dec 2;66(6):684-93. Thromb Haemost. 1991. PMID: 1796414

6

Comparative thrombolytic properties of bolus injections and continuous infusions of a chimeric (t-PA/u-PA) plasminogen activator in a hamster pulmonary embolism model.

Lu HR, Lijnen HR, Stassen JM, Collen D. Lu HR, et al. Among authors: collen d. Blood. 1991 Jul 1;78(1):125-31. Blood. 1991. PMID: 1906351 Free article.

7

Thrombolytic and pharmacokinetic properties of chimeric tissue-type and urokinase-type plasminogen activators.

Collen D, Lu HR, Lijnen HR, Nelles L, Stassen JM. Collen D, et al. Circulation. 1991 Sep;84(3):1216-34. doi: 10.1161/01.cir.84.3.1216. Circulation. 1991. PMID: 1909220

8

Thrombolytic and pharmacokinetic properties of a conjugate of recombinant single-chain urokinase-type plasminogen activator with a monoclonal antibody specific for cross-linked fibrin in a baboon venous thrombosis model.

Collen D, Dewerchin M, Rapold HJ, Lijnen HR, Stassen JM. Collen D, et al. Circulation. 1990 Nov;82(5):1744-53. doi: 10.1161/01.cir.82.5.1744. Circulation. 1990. PMID: 2121385

9

Thrombolytic properties of human tissue-type plasminogen activator, single-chain urokinase-type plasminogen activator, and synergistic combinations in venous thrombosis models in dogs and rabbits.

Spriggs DJ, Stassen JM, Hashimoto Y, Collen D. Spriggs DJ, et al. Among authors: collen d. Blood. 1989 Apr;73(5):1207-12. Blood. 1989. PMID: 2495034 Free article.

10

Potentiation by heparin fragments of thrombolysis induced with human tissue-type plasminogen activator or human single-chain urokinase-type plasminogen activator.

Stassen JM, Juhan-Vague I, Alessi MC, De Cock F, Collen D. Stassen JM, et al. Among authors: collen d. Thromb Haemost. 1987 Oct 28;58(3):947-50. Thromb Haemost. 1987. PMID: 2829381

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

812 results

Search Page

Filters